Guardion Health Sciences, Inc. GHSI
At closeMar 9, 2026, 4:00 PM EDT
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 4.35M
- Revenue (ttm)
- 12.23M
- Profit margin
- 52.13%
- EPS (ttm)
- -4.11
- Shares out
- 1.35M
- P/E ratio
- -0.79
- Forward P/E
- -3.16
- Dividend
- 20.00 (174.67%)
- Ex-dividend date
- Sep 23, 2024
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 664
- Avg volume
- 120.95K
- Open
- 3.25
- Previous close
- 3.25
- Day's range
- 3.25 – 3.25
- 52-week range
- 3.04 – 18.00
- Beta
- 0.71
- Analysts
- Buy
- Earnings date
- Aug 13, 2024
2Y -4.67 (-58.96%)
Key statistics
- Enterprise value
- -10.69M
- PEG ratio
- 0.00
- Price / sales
- 0.36
- Price / book
- 0.30
- Dividend yield
- 174.67%
- Payout ratio
- 0.00%
- Revenue growth
- -8.40%
- Free cash flow
- 1.38M
- Total cash
- 14.82M
- Total debt
- 0
- Return on equity
- -50.26%
- Short % of float
- 2.56%
- 50-day average
- 5.92
- 200-day average
- 8.37
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 13, 2024
Expected Aug 13, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
About Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- United States
- Website
- guardionhealth.com
News
Guardion Health Sciences Announces Declaration of Cash Distribution 
Guardion Health Sciences Announces Filing of Certificate of Dissolution 
12 Consumer Staples Stocks Moving In Friday's After-Market Session 
12 Consumer Staples Stocks Moving In Thursday's After-Market Session 
12 Consumer Staples Stocks Moving In Tuesday's Intraday Session 
12 Consumer Staples Stocks Moving In Monday's After-Market Session 
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock 
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024 
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution 
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
Your note
Sign in to keep a note on GHSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| RADOFF BRADLEY LOUIS | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 25, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 2.95% | 37,620 | 292.68K | Jun 29, 2023 |
| Blackrock Inc. | 0.79% | 10,030 | 78.03K | Jun 29, 2023 |
| Barclays Plc | 0.07% | 900 | 7.00K | Jun 29, 2023 |
| Morgan Stanley | 0.05% | 659 | 5.13K | Jun 29, 2023 |
| Citigroup Inc. | 0.03% | 373 | 2.90K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.25% | 3,165 | 24.62K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.15% | 1,938 | 11.96K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 527 | 3.25K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.03% | 375 | 2.31K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.03% | 430 | 2.65K | May 30, 2023 |